Insider Transactions in Q1 2021 at Angion Biomedica Corp. (ANGN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2021
|
John F. Neylan Officer |
SELL
Open market or private sale
|
Direct |
442
-1.14%
|
$8,398
$19.13 P/Share
|
|
Mar 13
2021
|
Jennifer J Rhodes Officer |
SELL
Open market or private sale
|
Direct |
499
-1.43%
|
$9,980
$20.45 P/Share
|
|
Feb 13
2021
|
Jennifer J Rhodes Officer |
SELL
Open market or private sale
|
Direct |
457
-1.3%
|
$8,683
$19.54 P/Share
|
|
Feb 09
2021
|
Victor F Ganzi Director |
SELL
Open market or private sale
|
Direct |
246,720
-29.97%
|
$3,947,520
$16.0 P/Share
|
|
Feb 09
2021
|
Victor F Ganzi Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
367,590
+30.87%
|
$2,205,540
$6.43 P/Share
|
|
Feb 09
2021
|
Victor F Ganzi Director |
BUY
Conversion of derivative security
|
Direct |
68,863
+7.17%
|
$757,493
$11.57 P/Share
|
|
Feb 09
2021
|
Itzhak Goldberg Director |
SELL
Payment of exercise price or tax liability
|
Direct |
38,353
-1.82%
|
$613,648
$16.0 P/Share
|
|
Feb 09
2021
|
Gilbert S Omenn Director |
BUY
Conversion of derivative security
|
Indirect |
61,657
+25.87%
|
$678,227
$11.57 P/Share
|
|
Feb 09
2021
|
Karen J Wilson Director |
BUY
Conversion of derivative security
|
Direct |
18,718
+50.0%
|
$205,898
$11.57 P/Share
|
|
Feb 09
2021
|
Jay Venkatesan Director |
BUY
Conversion of derivative security
|
Direct |
165,356
+6.05%
|
$1,818,916
$11.57 P/Share
|
|
Feb 09
2021
|
Jay Venkatesan Director |
SELL
Open market or private sale
|
Direct |
159,177
-11.64%
|
$2,546,832
$16.0 P/Share
|
|
Feb 09
2021
|
Jay Venkatesan Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
237,152
+14.15%
|
$1,422,912
$6.43 P/Share
|
|
Feb 09
2021
|
Jay Venkatesan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
31,966
-2.99%
|
$511,456
$16.0 P/Share
|